Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets

Area of Science:

• Oncology
• Cancer Metabolism
• Neuro-oncology

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with a poor patient prognosis.
• Treatment advancements have not significantly improved median survival rates.
• Cellular heterogeneity and adaptability pose challenges in GBM treatment.

Purpose of the Study:

• To explore the role of metabolic reprogramming in Glioblastoma (GBM) survival and proliferation.
• To highlight key metabolic alterations in GBM, including the Warburg effect and glutamine metabolism.
• To underscore the potential of targeting GBM metabolism for novel therapeutic strategies.

Main Methods:

• Review of existing literature on GBM cellular metabolism.
• Analysis of metabolic reprogramming processes in cancer cells.
• Identification of key metabolic pathways involved in GBM growth.

Main Results:

• GBM cells exhibit significant metabolic reprogramming to support rapid growth.
• Key alterations include the Warburg effect, altered glutamine metabolism, fatty acid synthesis, and TCA cycle modifications.
• Increased glutamine uptake and utilization are crucial for GBM survival.

Conclusions:

• Metabolic reprogramming is central to GBM cell survival and proliferation.
• Targeting these metabolic adaptations presents a promising avenue for developing effective GBM therapies.
• Further understanding of GBM metabolism can lead to improved treatment interventions.